Search the Newsreel

TD Asset Management Inc Increases Position in Bristol Myers Squibb Company $BMY

KBC Group NV Has $245.71 Million Stock Holdings in Bristol Myers Squibb Company $BMY

North Dakota State Investment Board Boosts Holdings in Bristol Myers Squibb Company $BMY

Pershing Square (PS) Stock Still Looks Stretched After A 69% Run

Why Madison Square Garden Entertainment (MSGE) Is Up 11.6% After Strong FY 2026 Earnings Beat And Guidance

What Does Bristol Myers Squibb (BMY) Risk From The Revived $6.7 Billion Lawsuit?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Bristol Myers Squibb (NYSE:BMY) is facing a revived US$6.7b lawsuit after a federal appeals court reinstated claims tied to its Celgene acquisition. Plaintiffs allege the …

Madison Square Garden Hasn't Paid Property Taxes Since 1982. Now the Knicks Are Worth $11.75 Billion

The article discusses the astronomical $11.75 billion valuation of the New York Knicks, driven by a recent championship, a massive national media deal, loosened private equity rules, and a perpetual property tax exemption for Madison Square Garden. It highlights how fan devotion translates into …

Bristol-Myers-Squibb-Aktie legt nach Zenbexus-Approval zu

Oxford Square Capital Corp. Plans Monthly Dividend of $0.04 (NASDAQ:OXSQ)

Meyer Handelman Co. Lowers Stock Position in Bristol Myers Squibb Company $BMY

Citi Remains a Hold on Bristol-Myers Squibb (BMY)

Bristol Myers Squibb Company $BMY Shares Acquired by Vontobel Holding Ltd.

Massachusetts Financial Services Co. MA Sells 102,388 Shares of Bristol Myers Squibb Company $BMY

Crew Capital Management Ltd Makes New Investment in Bristol Myers Squibb Company $BMY

Ascent Group LLC Has $3.21 Million Stake in Bristol Myers Squibb Company $BMY

Madison Square Garden (NYSE:MSGS) Downgraded to Sell Rating by Wall Street Zen

How First CELMoD MRD-Based Approval in Myeloma At Bristol Myers Squibb (BMY) Has Changed Its Investment Story

Bristol Myers Squibb (BMY) Stock May Be 46% Undervalued As FDA Approval Lands

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Bristol-Myers Squibb stock has delivered a 38.1% gain over the past year, while valuation …

Is Madison Square Garden Sports (MSGS) Pricey On Earnings And Spin Off Hopes?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Madison Square Garden Sports (MSGS) is back in focus after its August 13 earnings release, which showed fourth quarter sales of US$278.75 million and …

Die Bristol-Myers-Squibb-Aktie legt nach starken Quartalszahlen zu

PS|Pershing Square Ord Shs|Price:40.640|Chg%:-0.760

Pershing Square Holdings Ltd (LSE:PSH) (Q2 2026) Earnings Call Highlights: Strategic Leverage ...

This article first appeared on GuruFocus. Net Asset Value (NAV) Growth: The company highlighted that the underlying portfolio companies are expected to compound at a high rate, driving NAV growth over time. Fee and Performance Fee Revenue: Expected to increase as NAV rises, flowing …

Swissquote Group Holding SA (WBO:SQN2) (H1 2026) Earnings Call Highlights: Record Client Assets ...

This article first appeared on GuruFocus. Client Assets: Reached a record CHF96.3 billion, up 19.8% year-over-year. Net New Money: CHF5.1 billion in H1 2026, the second-best half-year result ever, driven by Switzerland (CHF2.7 billion) and Europe (CHF1.7 billion). Net Revenues: CHF364.2 million, up 1.7% …

Madison Square Garden Sports (MSGS) Stock Profit Rebound Faces Cost Pressure

FaZe owner GameSquare reports $28.2m net loss in the first half of 2026

GameSquare Holdings, parent company of FaZe Esports, reported a net loss of $28.2 million for the first half of 2026, including a $10.6 million loss in Q2 2026. Despite a 117% increase in revenue to $33.0 million, significant unrealized losses of $22.4 million from …

Pershing Square's revamped portfolio's biggest bets are on Uber, Brookfield, and Microsoft

[The Hamptons International Film Festival SummerDocs Series Screening Of BETTING ON ZERO] Matthew Eisman Bill Ackman's Pershing Square Inc. disclosed the exact size of its portfolio holdings, with among its largest bets in Brookfield (BN [https://seekingalpha.com/symbol/BN]), Uber Technologies (UBER [https://seekingalpha.com/symbol/UBER]), and Microsoft. Its 34.3M …

MSG Sports Publicly Files Form 10 Registration Statement for Proposed Spin-Off of Rangers Business from Knicks Business

NEW YORK, August 14, 2026--(BUSINESS WIRE)--Madison Square Garden Sports Corp. (NYSE: MSGS) ("MSG Sports" or the "Company") today announced that it is continuing to make progress on the proposed spin-off of its New York Rangers business from its New York Knicks business, with the …

MSG Sports Targets Rangers Spin-Off by October As It Looks to Unlock Value

Madison Square Garden Sports (MSGS) reported strong fiscal fourth-quarter results, surpassing analyst expectations, primarily driven by the New York Knicks' NBA championship run. The company saw significant increases in playoff-related revenue and is targeting a spin-off of its Rangers business by the end of …

SEALSQ Corp (NASDAQ: LAES) details rapid 2026 growth, $485M cash and quantum push

SEALSQ Corp reported strong preliminary H1 2026 results with approximately $11 million in revenue, a 120% year-over-year increase, and $485 million in cash and short-term investments. The company reaffirmed its 2026 revenue guidance of 50%-100% growth and highlighted significant progress in its post-quantum technology, …

AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?

Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma

Bristol Myers Squibb's drug, iberdomide (Zenbexus), has received accelerated FDA approval for treating multiple myeloma, making it the first FDA-approved cereblon-modulating (CELMoD) protein degrader. Zenbexus is indicated for use with Darzalex Faspro and dexamethasone in adults who have received at least one prior line …

Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Bristol Myers Squibb (BMY) is back in focus after the FDA granted accelerated approval for ZENBEXUS in a multiple myeloma combination regimen, introducing …

Seth Klarman Just Quietly Bought a Piece of Bill Ackman’s Firm

Quick Read Seth Klarman's Baupost Group bought 392,000 shares of Pershing Square (PS), placing roughly $13 million behind Ackman's Berkshire-style listed management company pitch. PS shares climbed 17% before Baupost's filing disclosed the position, and only 3 of 10 analysts rate it a buy …